Understanding Genomic and Social Determinants of Cancer Immunotherapy Outcome across Ancestry
Journal of Thoracic Oncology(2023)
摘要
Compared with previous standards of care, the use of immune checkpoint inhibitors (ICI) has brought significant improvements in survival and quality of life for lung cancer patients. However, only a small proportion of these patients respond durably. People with different ancestries differ probabilistically in genetic factors, environmental exposures, and socio-economic conditions. Whether patients of different ancestry benefit equally from ICIs remains unclear.
更多查看译文
关键词
Immunotherapy,Disparities,Genomics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要